Skip to main content Skip to footer
Providers
Virtual Nodule ClinicLung Cancer ScreeningFeatured case studyInteroperability
Partners
Life SciencesResearch
Patients
Lung nodulesLung cancerLung cancer careLung disease
Resources
PublicationsReimbursementMedia kitCase studiesWebinars
News
NewsBlogEvents
Company
Vision & MissionExecutive Team & BoardAdvisory boardsTechnologyCareers
Contact us
Providers
Virtual Nodule ClinicLung Cancer ScreeningFeatured case studyInteroperability
Partners
Life SciencesResearch
Patients
Lung nodulesLung cancerLung cancer careLung disease
Resources
PublicationsReimbursementMedia kitCase studiesWebinars
News
NewsBlogEvents
Company
Vision & MissionExecutive Team & BoardAdvisory boardsTechnologyCareers
LoginContact us
  • Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

    August 13, 2026
    Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
  • Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated Lung Cancer Diagnosis

    June 15, 2026
    Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive…
  • Tanner Health and Healthliant Ventures Partner with Optellum to Bring AI for Lung Health to the Region

    June 10, 2026
    Tanner Health and Healthliant Ventures announce the launch of Optellum’s Virtual Nodule Clinic® (VNC), an artificial intelligence (AI) platform designed…
  • Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

    June 4, 2026
    OXFORD, United Kingdom and HOUSTON, United States, June 4, 2026 - Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it…
  • Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients

    June 3, 2026
    Massive Bio and Optellum today announced a collaboration to bridge early lung cancer detection with clinical trial access for patients…
  • Cutting-edge AI is great, but how will your health system pay for it?

    May 29, 2026
    Optellum is the only Lung Nodule AI with named reimbursement by CMS 5 years and running. Our US health system…
  • Earlier detection meets the clock: When the 8-week window to surgery can make or break lung cancer survival

    May 20, 2026
    In this next topic of our Learning Center Highlight series, we’ll explore why the time between detecting a lung nodule…
  • Optellum Virtual Nodule Clinic (VNC) vs. RevealDx RevealAI-Lung

    May 18, 2026
    Incidental lung nodule care requires more than a one-time risk output. Thoracic programs are multidisciplinary teams comprising pulmonologists, radiologists,...
  • Lung nodule care doesn’t stop at the radiology report. So why should the AI?

    May 17, 2026
    Incidental lung nodules are managed by multidisciplinary teams, not one specialty alone. Our LCP AI remains the only FDA-cleared AI…
  • Meet the Thoracic Champion series: An interview with Samantha Otis, NP-C at Wellstar MCG Health Medical Center in Augusta, Georgia

    May 8, 2026
    My name is Samantha Otis and I am a Nurse Practitioner working with MCG's Lung Cancer Screening Program. I get…
  • 1
  • 2
  • 3
  • …
  • 16
  • →
Optellum is a lung health company developing the lung precision care platform to redefine the efficient management, early diagnosis, and optimal care of lung disease patients.
Optellum Ltd.
5 Kings Meadow, Osney Mead, Ferry Hinksey Road, Oxford, Oxfordshire, England, OX2 0DP, United Kingdom
Optellum Inc.
TMC Innovation Institute, 2450 Holcombe Blvd, Suite X,
Houston, TX 77021, United States
CompanyVision & MissionExecutive Team & BoardAdvisory boardsTechnologyCareers
PartnersCommercial growthClinical developmentResearch collaborationData sharing
ResourcesPublicationsReimbursementMedia kit
Case studies
Webinars
ProvidersVirtual Nodule ClinicLung Cancer ScreeningFeatured case studyInteroperability
PatientsLung nodulesLung cancerLung cancer careLung disease
NewsNewsBlogEvents
Copyright 2026 Optellum Ltd
Trust Center
Cookie PolicyPrivacy PolicyAccessibility
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}